Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAksoy-Sagirli, Pinar
dc.contributor.authorCakmakoglu, Bedia
dc.contributor.authorIsbir, Turgay
dc.contributor.authorKaytan-Saglam, Esra
dc.contributor.authorKizir, Ahmet
dc.contributor.authorTopuz, Erkan
dc.contributor.authorBerkkan, Hakan
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T16:04:08Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T16:04:08Z
dc.date.issued2011
dc.identifier.issn0250-7005
dc.identifier.issn1791-7530
dc.identifier.urihttp://hdl.handle.net/11446/3241
dc.descriptionWOS: 000292631300029en_US
dc.descriptionPubMed ID: 21737645en_US
dc.description.abstractAim: The purpose of the present study was to investigate the possible association of paraoxonase-1 (PON1) 192/55 polymorphisms with lung cancer (LC) risk in a Turkish population. Materials and Methods: A population-based, case-control study was carried out, including 223 patients with LC and 234 controls. The frequencies of PON1 192155 genotypes were compared in patient and control groups using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results: Distribution of PON1 192 R (+) genotype was found to be significantly higher in patients with LC compared to the controls (odds ratio: 1.497, 95% confidence interval: 1.034-2.166). This difference was especially noteworthy in patients with small cell carcinoma and squamous cell carcinoma. Conclusion: This is the first case-control study on the association between PON1 polymorphisms and LC susceptibility in a Turkish population. Our results suggest that PON1 192 polymorphsim is associated with an increased risk of LC in the Turkish population and may be a useful genetic marker for small cell and squamous cell carcinoma.en_US
dc.description.sponsorshipIstanbul University [T-561/21102004, UDP-4443/15102009]en_US
dc.description.sponsorshipThis research was supported in part by the following grants: Istanbul University Scientific Research Projects, Project no: T-561/21102004 and UDP-4443/15102009.en_US
dc.language.isoengen_US
dc.publisherINT INST ANTICANCER RESEARCHen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectParaoxonase 1en_US
dc.subjectPON1en_US
dc.subjectpolymorphismen_US
dc.subjectlung cancer risken_US
dc.subjectSNPen_US
dc.titleParaoxonase-1 192/55 Polymorphisms and the Risk of Lung Cancer in a Turkish Populationen_US
dc.typearticleen_US
dc.relation.journalANTICANCER RESEARCHen_US
dc.departmentDBÜen_US
dc.identifier.issue6en_US
dc.identifier.volume31en_US
dc.identifier.startpage2225en_US
dc.identifier.endpage2229en_US
dc.contributor.authorID0000-0001-7960-9131en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Aksoy-Sagirli, Pinar] Istanbul Univ, Fac Pharm, Dept Biochem, TR-34116 Istanbul, Turkey -- [Cakmakoglu, Bedia] Istanbul Univ, Expt Med Res Inst, TR-34116 Istanbul, Turkey -- [Kaytan-Saglam, Esra -- Kizir, Ahmet -- Topuz, Erkan] Istanbul Univ, Inst Oncol, TR-34116 Istanbul, Turkey -- [Isbir, Turgay] Yeditepe Univ, Fac Med, Istanbul, Turkey -- [Berkkan, Hakan] Istanbul Bilim Univ, Fac Med, Dept Biochem, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster